New pharma and biotech manufacturing facilities and expansions announced worldwide for 2024

[Adobe Stock]

The pharma and biotech sectors continue to rapidly transform in response to rising demand for innovative therapies. While less fortunate players are shedding jobs, in 2024, major players like AbbVie, AGC Biologics, and Amgen are investing heavily in new manufacturing facilities worldwide, from Singapore to Japan and the U.S. Companies expanding in North Carolina, Ohio, and Iceland signal a push to make innovative medicines and advanced therapies more accessible globally.

The map below shows select new plant openings and expansions announced in 2024, with 8 in North America and 15 in other regions

North America United States Amgen opened a new AI-enabled biomanufacturing facility in New Albany, Ohio, employing roughly 400 people. The $365 million investment features automation, AI, and data-driven manufacturing processes. Amgen also plans to advance drug discovery using AI models at deC…
Read more
  • 0